Media

The Biotechnology Industry Organization (BIO) today announced that it will showcase a series of unique sessions at this year’s Livestock Biotech Summit...
Sessions to focus on the FDA Breakthrough Therapy Designation Process, IPO Market, and BioCentury’s Back to School issue

Press Releases

Aug 29 2000
August 29, 2000 The Honorable George W. BushGovernor of TexasP.O. Box 12428Austin, Texas 78711 Dear Governor Bush: As the presidential campaigns begin to focus...
Aug 29 2000
WASHINGTON, D.C., August 29, 2000 - Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement on the national...
Aug 21 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization [BIO] issued the following statement in response to a...
Jul 27 2000
WASHINGTON, D.C. (July 27, 2000) Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today announced that Stephan Lawton, a senior partner in...
Jul 25 2000
WASHINGTON, D.C. (July 25, 2000) The Biotechnology Industry Organization (BIO) today applauded dismissal in federal court of a Greenpeace lawsuit against...
Jul 21 2000
WASHINGTON, D.C. (July 21, 2000) A Biotechnology Industry Organization (BIO) survey found that more than one-quarter billion people worldwide have benefited...
Jul 20 2000
(Carl B. Feldbaum, president of the Biotechnology Industry Organization [BIO] issued the following statement today regarding the formation of the Congressional...
Jul 18 2000
WASHINGTON, D.C. (July 18, 2000)- Biotechnology IndustryOrganization (BIO) President Carl B. Feldbaum said BIO supports the FDA’s powers regarding...
Jul 13 2000
WASHINGTON, D.C. (July 13, 2000) Executives from two Biotechnology Industry Organization (BIO) member companies testified today at a U.S. House Judiciary...


Biotechnology News

September 18, 2014

NEW YORK--(BUSINESS WIRE)--SIGA Technologies, Inc. (NASDAQ:SIGA), a company specializing in the development and commercialization of solutions for serious unmet medical...

September 18, 2014

SEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and...

September 17, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that Mike McMullen, senior vice president, Agilent, and president of the company’s...

September 17, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc (NYSE: COV) today announced that its Board of Directors has declared a 13% increase in the quarterly dividend rate, from $0....